G. Shirakami et al., THE EFFECTS OF ATRIAL-NATRIURETIC-PEPTIDE INFUSION ON HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES DURING GASTRECTOMY, Anesthesia and analgesia, 85(4), 1997, pp. 907-912
Atrial natriuretic peptide (ANP) antagonizes the reninangiotensin-aldo
sterone, adrenocorticotropic hormone-cortisol, vasopressin, and endoth
elin systems. Surgical injury stimulates these systems and causes vaso
constriction and antidiuresis. We assessed the hemodynamic, renal, and
endocrine effects of continuous intravenous infusion of ANP in patien
ts anesthetized with sevoflurane undergoing gastrectomy. ANP (0.1 mu g
.kg(-1).min(-1); ANP group, n = 9) or saline (control group, n = 9) wa
s infused continuously for 3 h from the start of the operation. The AN
P group showed much higher urinary volume and sodium, potassium, and c
hloride excretion than the control group, although the former had lowe
r arterial blood pressure. ANP infusion slightly inhibited aldosterone
secretion and initially tended to inhibit renin secretion stimulated
by surgery, but it did not affect surgery-induced increases in the pla
sma concentrations of vasopressin, adrenocorticotropic hormone, cortis
ol, or endothelin. Two patients in the ANP group experienced excessive
hypotension, one experienced bradycardia, and two experienced mild hy
poxemia, which required treatment but were resolved easily. These find
ings suggest that ANP infusion may be used with caution for controllin
g renal function and arterial blood pressure during surgery. Implicati
ons: Continuous intravenous infusion of atrial natriuretic peptide, 0.
1 mu g.kg(-1).min(-1), during gastrectomy was associated with higher w
ater and sodium excretion and lower arterial blood pressure. It tended
to inhibit the renin-angiotensin-aldosterone system compared with sal
ine infusion, which suggests that atrial natriuretic peptide may be us
eful for intraoperative circulation control.